Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Merck a leading science and technology company today announced that its Life Science business sector has been awarded a million contract award for the construction of a lateral flow membrane production facility over a threeyear period at the company...
Oramed Pharmaceuticals Inc a clinicalstage pharmaceutical company focused on the development of oral drug delivery platforms today announced that its subsidiary Oravax Medical has signed a Cooperation and Purchase Agreement with Vietnambased Tan Than...
Aditxt Inc a biotech innovation company with a mission to improve the health of the immune system today announced it had signed an amendment to its February Exclusive License Agreement with Stanford University extending Aditxts exclusive right to l...
Aditxt Inc a biotech innovation company with a mission to improve the health of the immune system has signed a share exchange agreement to acquire AiPharma Global Holdings LLC a whollyowned subsidiary of AiPharma Group Ltd AiPharma The share exchange...
Celularity Inc a clinicalstage biotechnology company developing placentalderived allogeneic cell therapies today announced the US Food and Drug Administration FDA has granted Fast Track Designation for its nongenetically modified cryopreserved human...
Sutro Biopharma Inc a clinicalstage drug discovery development and manufacturing company focused on the application of precise protein engineering and rational design to create nextgeneration cancer and autoimmune therapeutics today announced an excl...
Regor Therapeutics a clinicalstage biotech company announced authorization from the US Food and Drug Administration FDA to proceed with Regors Phase clinical development plans for RGTB RGTB is a new generation CDK small molecule inhibitor with an op...
Merck known as MSD outside the United States and Canada and Ridgeback Biotherapeutics today announced that Japans Ministry of Health Labor and Welfare has granted Special Approval for Emergency in Japan for molnupiravir an investigational oral antivi...
Sosei Group Corporation announces that in connection with the Collaboration and License Agreement License Agreement with Neurocrine Biosciences Inc Neurocrine Biosciences announced November the applicable waiting period under the HartScottRodino An...
Merck known as MSD outside the United States and Canada and Ridgeback Biotherapeutics today announced that the US Food and Drug Administration FDA has granted Emergency Use Authorization EUA for molnupiravir an investigational oral antiviral MK EIDD...
